- The antiaggregatory ASA therapy improves insulin resistance and hyper…
Number of the records: 1  

The antiaggregatory ASA therapy improves insulin resistance and hyperlipoproteinemia in patients with advanced atherosclerosis

  1. Authority Gajdoš, Miroslav (Author)
    TitleThe antiaggregatory ASA therapy improves insulin resistance and hyperlipoproteinemia in patients with advanced atherosclerosis / M. Gajdoš, V. Spustová, R. Dzúrik
    Another responsib. Spustová, Viera (Author)
    Dzúrik, Rastislav, 1929-2014 (Author)
    European Atherosclerosis Society Kongres (66. : 1996 : Florence, Taliansko)
    Phys.des.Tab.
    In Ateroskleróza. -- ISSN 1335-2253. -- Roč. 1, č. 2 (1997), s. 56
    Call numberC 2971
    MeSH Subject artérioskleróza - diagnostika
    terapia trombolytická - využitie
    salicyláty - klasifikácia
    hyperlipoproteinémie - diagnostika
    rezistencia inzulínová - imunológia
    kongresy ako téma
    systematics616.13-004.6:615.273.55:061.3
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.